Taiwan · Delayed Price · Currency is TWD Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 12.76 billion. The enterprise value is 9.04 billion.
| Market Cap | 12.76B |
| Enterprise Value | 9.04B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
TPEX:6620 has 166.53 million shares outstanding. The number of shares has increased by 10.88% in one year.
| Current Share Class | 166.53M |
| Shares Outstanding | 166.53M |
| Shares Change (YoY) | +10.88% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 2.13% |
| Float | 97.01M |
Valuation Ratios
The trailing PE ratio is 25.35 and the forward PE ratio is 14.88.
| PE Ratio | 25.35 |
| Forward PE | 14.88 |
| PS Ratio | 10.53 |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.95 |
| P/FCF Ratio | 20.14 |
| P/OCF Ratio | 19.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.65, with an EV/FCF ratio of 14.27.
| EV / Earnings | 18.43 |
| EV / Sales | 7.46 |
| EV / EBITDA | 14.65 |
| EV / EBIT | 19.97 |
| EV / FCF | 14.27 |
Financial Position
The company has a current ratio of 8.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.97 |
| Quick Ratio | 8.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.06 |
| Interest Coverage | 168.91 |
Financial Efficiency
Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 25.01%.
| Return on Equity (ROE) | 10.60% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 25.01% |
| Return on Capital Employed (ROCE) | 8.87% |
| Weighted Average Cost of Capital (WACC) | 7.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6620 has paid 122.95 million in taxes.
| Income Tax | 122.95M |
| Effective Tax Rate | 20.05% |
Stock Price Statistics
The stock price has decreased by -5.07% in the last 52 weeks. The beta is 0.67, so TPEX:6620's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -5.07% |
| 50-Day Moving Average | 86.56 |
| 200-Day Moving Average | 88.25 |
| Relative Strength Index (RSI) | 39.80 |
| Average Volume (20 Days) | 889,660 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 1.21 billion and earned 490.22 million in profits. Earnings per share was 3.02.
| Revenue | 1.21B |
| Gross Profit | 985.90M |
| Operating Income | 453.87M |
| Pretax Income | 613.17M |
| Net Income | 490.22M |
| EBITDA | 605.54M |
| EBIT | 453.87M |
| Earnings Per Share (EPS) | 3.02 |
Balance Sheet
The company has 3.73 billion in cash and 41.03 million in debt, with a net cash position of 3.69 billion or 22.15 per share.
| Cash & Cash Equivalents | 3.73B |
| Total Debt | 41.03M |
| Net Cash | 3.69B |
| Net Cash Per Share | 22.15 |
| Equity (Book Value) | 5.02B |
| Book Value Per Share | 30.17 |
| Working Capital | 3.71B |
Cash Flow
In the last 12 months, operating cash flow was 662.01 million and capital expenditures -28.72 million, giving a free cash flow of 633.29 million.
| Operating Cash Flow | 662.01M |
| Capital Expenditures | -28.72M |
| Depreciation & Amortization | 151.67M |
| Net Borrowing | -13.24M |
| Free Cash Flow | 633.29M |
| FCF Per Share | 3.80 |
Margins
Gross margin is 81.41%, with operating and profit margins of 37.48% and 40.48%.
| Gross Margin | 81.41% |
| Operating Margin | 37.48% |
| Pretax Margin | 50.63% |
| Profit Margin | 40.48% |
| EBITDA Margin | 50.00% |
| EBIT Margin | 37.48% |
| FCF Margin | 52.29% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.59%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.59% |
| Dividend Growth (YoY) | 37.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.20% |
| Buyback Yield | -10.88% |
| Shareholder Yield | -8.30% |
| Earnings Yield | 3.84% |
| FCF Yield | 4.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |